• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

己酸羟孕酮预防早产研究中的种族和族裔代表性:一项系统综述

Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review.

作者信息

Smith Megan M, Weber Jeremy M, Truong Tracy, Swamy Geeta K, Wheeler Sarahn M

机构信息

Duke University School of Medicine, Durham, NC, USA.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.

出版信息

J Perinat Med. 2022 Aug 29;50(7):970-976. doi: 10.1515/jpm-2021-0425. Print 2022 Sep 27.

DOI:10.1515/jpm-2021-0425
PMID:36027908
Abstract

OBJECTIVES

The US preterm birth rate varies dramatically by race and ethnicity yet the racial and ethnic representation within studies evaluating 17-hydroxprogesterone caproate (17-P) for preterm birth prevention is unknown. The objectives of our study were to 1) examine the racial and ethnic representation of participants in 17-P preterm birth prevention studies, 2) evaluate adherence to the NIH race and ethnicity reporting guidelines and 3) compare racial and ethnic representation in research studies to national preterm birth incidence.

METHODS

We systematically reviewed US studies published between January 2000 and December 2019. Study participant's race and ethnicity were reported using descriptive statistics then compared to US 2017//2018 preterm birth data using Pearson's chi-square.

RESULTS

Eighteen studies met the inclusion criteria, 17 studies reported race, 11 studies reported ethnicity, and yet none of the studies followed the NIH criteria. Compared to 2017/2018 US preterm births, the proportion of black/African American study participants was significantly higher whereas the proportions of all other race categories were lower.

CONCLUSIONS

More detailed reporting of race and ethnicity is needed in 17-P literature. Black women appear to be well represented while other racial and ethnic groups may be understudied.

摘要

目的

美国的早产率因种族和族裔不同而有显著差异,但在评估己酸17-羟孕酮(17-P)预防早产的研究中,种族和族裔代表性情况尚不清楚。我们研究的目的是:1)检查参与17-P预防早产研究的参与者的种族和族裔代表性;2)评估对美国国立卫生研究院(NIH)种族和族裔报告指南的遵循情况;3)比较研究中的种族和族裔代表性与全国早产发生率。

方法

我们系统回顾了2000年1月至2019年12月发表的美国研究。使用描述性统计报告研究参与者的种族和族裔,然后使用Pearson卡方检验与美国2017//2018年早产数据进行比较。

结果

18项研究符合纳入标准,17项研究报告了种族,11项研究报告了族裔,但没有一项研究遵循NIH标准。与2017/2018年美国早产情况相比,黑人/非裔美国研究参与者的比例显著更高,而所有其他种族类别的比例则更低。

结论

17-P文献中需要更详细地报告种族和族裔情况。黑人女性似乎有充分的代表性,而其他种族和族裔群体可能研究不足。

相似文献

1
Racial and ethnic representation in 17-hydroxyprogesterone caproate preterm birth prevention studies: a systematic review.己酸羟孕酮预防早产研究中的种族和族裔代表性:一项系统综述
J Perinat Med. 2022 Aug 29;50(7):970-976. doi: 10.1515/jpm-2021-0425. Print 2022 Sep 27.
2
Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.种族和民族差异在使用 17-α 羟孕酮己酸酯预防早产中的应用。
Am J Obstet Gynecol. 2016 Mar;214(3):374.e1-6. doi: 10.1016/j.ajog.2015.12.054. Epub 2016 Jan 29.
3
Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth.使用 17-α-羟孕酮己酸酯治疗复发性早产高危人群的妊娠持续时间:一项回顾性队列研究。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100219. doi: 10.1016/j.ajogmf.2020.100219. Epub 2020 Sep 2.
4
Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.阴道用黄体酮与肌肉注射己酸羟孕酮预防复发性早产的随机对照试验
Am J Obstet Gynecol. 2022 May;226(5):722.e1-722.e12. doi: 10.1016/j.ajog.2022.02.012. Epub 2022 Feb 19.
5
Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.己酸17-α羟孕酮起始时的孕周与复发性早产
Am J Obstet Gynecol. 2017 Sep;217(3):371.e1-371.e7. doi: 10.1016/j.ajog.2017.05.022. Epub 2017 May 17.
6
Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.己酸17-α羟孕酮预防复发性自发性早产疗效的预测因素
Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.
7
Adjuvant 17-hydroxyprogesterone caproate in women withultrasound-indicated cerclage: a systematic review and meta-analysis.超声提示宫颈环扎术孕妇应用辅助 17-羟孕酮己酸酯:系统评价和荟萃分析。
J Matern Fetal Neonatal Med. 2020 Sep;33(18):3177-3184. doi: 10.1080/14767058.2019.1568406. Epub 2019 Jan 24.
8
Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth.有早产史的女性使用 17-羟孕酮己酸酯的依从率和结局。
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100166. doi: 10.1016/j.ajogmf.2020.100166. Epub 2020 Jun 25.
9
A systematic review and meta-analysis of randomized controlled trials comparing 17-alpha-hydroxyprogesterone caproate versus placebo for the prevention of recurrent preterm birth.一项比较 17-α-羟孕酮己酸酯与安慰剂预防复发性早产的随机对照试验的系统评价和荟萃分析。
Int J Gynaecol Obstet. 2019 Nov;147(2):156-164. doi: 10.1002/ijgo.12940. Epub 2019 Aug 28.
10
Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention.17-α羟孕酮己酸酯用于预防复发性自发性早产的利用、依从性和结局。
Curr Med Res Opin. 2021 Sep;37(9):1667-1675. doi: 10.1080/03007995.2021.1933928. Epub 2021 Jun 7.